Akari Therapeutics Plc (AKTX) Financials
AKTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-06-30 | 8.0 million | 5.2 million |
2023-03-31 | 8012 | 5231 |
2022-12-31 | 13831 | 12040 |
2022-09-30 | 13831 | 12040 |
AKTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-06-30 | -4786 | 270 |
2023-03-31 | -4786 | 270 |
2022-12-31 | -3940 | 256 |
2022-09-30 | -3940 | 256 |
AKTX Net Income
No data available :(
AKTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-06-30 | 7.2 million | - | - |
2023-03-31 | 7180 | - | - |
2022-12-31 | 13249 | - | - |
2022-09-30 | 13249 | - | - |
AKTX Shares Outstanding
AKTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-06-30 | - | 1627 | 2977 | - |
2023-03-31 | - | 1627 | 2977 | - |
2022-12-31 | - | 3444 | 3728 | - |
2022-09-30 | - | 3444 | 3728 | - |
AKTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-06-30 | - | - |
2023-03-31 | - | - |
2022-12-31 | - | - |
2022-09-30 | - | - |
AKTX
Price: $1.18
52 week price:
Earnings Per Share: -2.04 USD
P/E Ratio: -1
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 16739
Ebitda: -8.5 millionMarket Capitalization: 9.6 million